Insulin Glulisine
CAS 207748-29-6Biologic
Overview
Insulin Glulisine is a rapid-acting insulin analog used to improve blood sugar control in adults and children with diabetes mellitus. It is designed for subcutaneous administration and has a faster onset and shorter duration of action compared to regular human insulin.
Therapeutic areas
Diabetes
Verified Supplier Partner
Do you supply Insulin Glulisine? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.